Literature DB >> 8866941

Fluvoxamine increases the clozapine serum levels significantly.

H J Koponen1, E Leinonen, U Lepola.   

Abstract

In this case report we describe an interaction between clozapine and fluvoxamine in two physically healthy patients meeting the DSM-IIIR criteria for paranoid schizophrenia. The substantial rise of clozapine serum levels suggest that caution should be exercised when combining fluvoxamine with clozapine as the clozapine concentration may increase by a factor of 5-10.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8866941     DOI: 10.1016/0924-977x(95)00069-2

Source DB:  PubMed          Journal:  Eur Neuropsychopharmacol        ISSN: 0924-977X            Impact factor:   4.600


  11 in total

1.  Clinical impact of fluvoxamine-mediated long QTU syndrome.

Authors:  Amir M Nia; Kristina M Dahlem; Natig Gassanov; Hansjörg Hungerbühler; Uwe Fuhr; Fikret Er
Journal:  Eur J Clin Pharmacol       Date:  2011-06-29       Impact factor: 2.953

Review 2.  Interactions between the cytochrome P450 system and the second-generation antipsychotics.

Authors:  Trevor I Prior; Glen B Baker
Journal:  J Psychiatry Neurosci       Date:  2003-03       Impact factor: 6.186

Review 3.  Pharmacokinetic-pharmacodynamic relationship of the selective serotonin reuptake inhibitors.

Authors:  P Baumann
Journal:  Clin Pharmacokinet       Date:  1996-12       Impact factor: 6.447

Review 4.  The clinical potentials of adjunctive fluvoxamine to clozapine treatment: a systematic review.

Authors:  Christoffer Polcwiartek; Jimmi Nielsen
Journal:  Psychopharmacology (Berl)       Date:  2015-12-02       Impact factor: 4.530

Review 5.  Obsessive-compulsive disorder in schizophrenia: clinical characteristics and treatment.

Authors:  Michael Poyurovsky; Abraham Weizman; Ronit Weizman
Journal:  CNS Drugs       Date:  2004       Impact factor: 5.749

Review 6.  Fluvoxamine. An updated review of its use in the management of adults with anxiety disorders.

Authors:  D P Figgitt; K J McClellan
Journal:  Drugs       Date:  2000-10       Impact factor: 9.546

Review 7.  Fluvoxamine: a review of its therapeutic potential in the management of anxiety disorders in children and adolescents.

Authors:  S M Cheer; D P Figgitt
Journal:  Paediatr Drugs       Date:  2001       Impact factor: 3.022

Review 8.  Clozapine and therapeutic drug monitoring: is there sufficient evidence for an upper threshold?

Authors:  Gary Remington; Ofer Agid; George Foussias; Larissa Ferguson; Krysta McDonald; Valerie Powell
Journal:  Psychopharmacology (Berl)       Date:  2012-11-22       Impact factor: 4.530

9.  Clozapine augmentation strategies.

Authors:  James L Roerig
Journal:  Ment Health Clin       Date:  2019-11-27

10.  Possible pharmacogenetic factors in clozapine treatment failure: a case report.

Authors:  Eromona Whiskey; Graziella Romano; Matilda Elliott; Malcolm Campbell; Cholan Anandarajah; David Taylor; Koravangattu Valsraj
Journal:  Ther Adv Psychopharmacol       Date:  2021-07-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.